Revised IPI (R-IPI) for DLBCL
Revised IPI for DLBCL (Sehn 2007): a 0–5 count over age > 60, high LDH, advanced stage, > 1 extranodal site, and ECOG ≥ 2, grouped very good / good / poor.
Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Age > 60 years
- Yes
- LDH above normal
- Yes
- Ann Arbor stage III–IV
- Yes
- > 1 extranodal site
- No
- ECOG performance status ≥ 2
- No
Result: R-IPI 3 of 5 factors -- Poor risk group; 4-year PFS ~53%, OS ~55%. Counted: age > 60, LDH above normal, stage III-IV.
The tool opens with these values already filled in. Replace them with your own.
What the result means
- 0
- Very good; 4-year PFS ~94%, OS ~94%.
- 1-2
- Good; 4-year PFS ~80%, OS ~79%.
- 3-5
- Poor; 4-year PFS ~53%, OS ~55%.
What you enter
- Age > 60 years
- LDH above normal
- Ann Arbor stage III–IV
- > 1 extranodal site
- ECOG performance status ≥ 2
How this is calculated
Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109(5):1857-1861. Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.